Your browser doesn't support javascript.
loading
Identification of genomic and molecular traits that present therapeutic vulnerability to HGF-targeted therapy in glioblastoma.
Sa, Jason K; Kim, Sung Heon; Lee, Jin-Ku; Cho, Hee Jin; Shin, Yong Jae; Shin, Hyemi; Koo, Harim; Kim, Donggeon; Lee, Mijeong; Kang, Wonyoung; Hong, Sung Hee; Kim, Jung Yong; Park, Young-Whan; Song, Seong-Won; Lee, Song-Jae; Joo, Kyeung Min; Nam, Do-Hyun.
Afiliación
  • Sa JK; Institute for Refractory Cancer Research, Samsung Medical Center, Seoul, Republic of Korea.
  • Kim SH; Research Institute for Future Medicine, Samsung Medical Center, Seoul, Republic of Korea.
  • Lee JK; Institute for Refractory Cancer Research, Samsung Medical Center, Seoul, Republic of Korea.
  • Cho HJ; Department of Anatomy and Cell Biology, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
  • Shin YJ; Institute for Refractory Cancer Research, Samsung Medical Center, Seoul, Republic of Korea.
  • Shin H; Research Institute for Future Medicine, Samsung Medical Center, Seoul, Republic of Korea.
  • Koo H; Institute for Refractory Cancer Research, Samsung Medical Center, Seoul, Republic of Korea.
  • Kim D; Research Institute for Future Medicine, Samsung Medical Center, Seoul, Republic of Korea.
  • Lee M; Institute for Refractory Cancer Research, Samsung Medical Center, Seoul, Republic of Korea.
  • Kang W; Research Institute for Future Medicine, Samsung Medical Center, Seoul, Republic of Korea.
  • Hong SH; Department of Neurosurgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
  • Kim JY; Institute for Refractory Cancer Research, Samsung Medical Center, Seoul, Republic of Korea.
  • Park YW; Department of Health Sciences and Technology, Samsung Advanced Institute for Health Sciences & Technology, Sungkyunkwan University, Seoul, Republic of Korea.
  • Song SW; Department of Health Sciences and Technology, Samsung Advanced Institute for Health Sciences & Technology, Sungkyunkwan University, Seoul, Republic of Korea.
  • Lee SJ; Institute for Refractory Cancer Research, Samsung Medical Center, Seoul, Republic of Korea.
  • Joo KM; Research Institute for Future Medicine, Samsung Medical Center, Seoul, Republic of Korea.
  • Nam DH; Institute for Refractory Cancer Research, Samsung Medical Center, Seoul, Republic of Korea.
Neuro Oncol ; 21(2): 222-233, 2019 02 14.
Article en En | MEDLINE | ID: mdl-29939324
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Biomarcadores de Tumor / Regulación Neoplásica de la Expresión Génica / Factor de Crecimiento de Hepatocito / Glioblastoma / Genómica / Anticuerpos Monoclonales Humanizados / Transcriptoma Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Animals / Female / Humans Idioma: En Revista: Neuro Oncol Asunto de la revista: NEOPLASIAS / NEUROLOGIA Año: 2019 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Biomarcadores de Tumor / Regulación Neoplásica de la Expresión Génica / Factor de Crecimiento de Hepatocito / Glioblastoma / Genómica / Anticuerpos Monoclonales Humanizados / Transcriptoma Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Animals / Female / Humans Idioma: En Revista: Neuro Oncol Asunto de la revista: NEOPLASIAS / NEUROLOGIA Año: 2019 Tipo del documento: Article